Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion

NCT01448018 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Central Retinal Vein Occlusion

Interventions

DRUG: ranibizumab
PROCEDURE: hemodilution

Sponsor

Centre Hospitalier Intercommunal Creteil